Optura announced a $17.5 million Series A round led by Salesforce Ventures, with participation from Echo Health Ventures and continued backing from Susa Ventures, Matrix Partners, and HC9 Ventures. The financing brings the company’s total funding to more than $25 million.
The company said the new capital will be used to expand AI capabilities, grow platform teams, and scale large language model partnerships as healthcare organizations increasingly seek measurable returns from artificial intelligence investments.
Based in Nashville, Optura positions its platform around ROAI (Return on AI Investment), helping healthcare enterprises evaluate AI business value, prioritize AI investments, and track enterprise-wide impact in real time.
According to the company, more than $2 billion in AI initiatives are currently loaded into the platform, with over $120 million in tracked value generated at 700% ROAI across active initiatives. The platform has also identified more than 250 new AI use cases for enterprise healthcare organizations.
Optura said its customer base includes organizations such as Independence Blue Cross, Prime Therapeutics, and Ardent Health.
The company’s platform is designed to map fragmented enterprise healthcare data into a unified intelligence layer, score AI use cases based on organizational readiness and cost, translate priorities into healthcare-specific AI agents, simulate projected returns before deployment, and monitor operational outcomes through a centralized dashboard.
Andy Fanning, Co-Founder and CEO of Optura, said:
KEY QUOTES:
“The hundreds of AI use cases coupled with the introduction of foundational models into healthcare markets, like Claude for Healthcare, are driving AI spend and increasing risk. It has also created a never-ending menu of point solutions, without an objective framework to help healthcare leaders measure the ROI on their AI investment decisions. We developed Optura to take out that guesswork and help healthcare organizations objectively measure results.”
Andy Fanning, Co-Founder and CEO, Optura
“Healthcare organizations are under growing pressure to move beyond AI experimentation and deliver measurable business outcomes. Optura is helping customers bring greater rigor and visibility to AI investment decisions , identifying high-value use cases, measuring impact and accelerating time to ROI. As enterprises look for more disciplined approaches to AI adoption, we believe Optura is well positioned to help lead that shift.”
Katie Thiry, Managing Director, Salesforce Ventures
“Optura is solving one of our industry’s biggest challenges: helping healthcare organizations structure and capture real value from AI programs. Its platform delivers the combination of data insights, tools and technology that we believe are consequential for moving into the next phase of AI transformation , accountability and orchestrated systems that deliver long-term value across the entire enterprise.”
Kurt Sheline, Partner, Echo Health Ventures
“The question for health plans is no longer whether to invest in AI; it’s whether those investments are actually delivering better outcomes for members. Optura answers that question for an organization like IBX, where every decision connects back to the people we serve, that kind of accountability and visibility isn’t optional; it’s how we ensure AI creates real value where it matters most.”
Michael R. Vennera, Executive Vice President and Chief Strategy, Technology and Operations Officer, Independence Blue Cross
